Thyroid Cancer in Kazakhstan: Component Analysis of Incidence Dynamics
(ندگان)پدیدآور
Igissinov, NurbekKozhakhmetov, SakenZhantubetova, MarzhanIgissinova, GulnurBilyalova, ZarinaAkpolatova, GulnurLyust, VladimirKoblandin, SarsembiTurebayev, DulatAdaibayev, KairatOmarbekov, ArdakTarzhanova, DinaraZhantureyeva, AkmaralEsseyev, Askarنوع مدرک
TextResearch Articles
زبان مدرک
Englishچکیده
Background: The International Agency for Research on Cancer (IARC) reports that 567,000 new cases of thyroidcancer (TC) were registered in the world in 2018, and the age-standardized incidence rate was 6.7 per 100,000. TheGlobal Cancer Observation forecasts a 35% growth in the number of new cases worldwide by 2040. The number ofpatients with TC in Kazakhstan is also increasing steadily. This investigation was the first epidemiological study of TCtrends by component analysis among the population of Kazakhstan. This paper presents the results of the componentanalysis of TC incidence trends in Kazakhstan. Methods: The study covers primary data of TC cases (ICD 10 – C73)registered throughout Kazakhstan from 2009 to 2018. TC incidence trends were evaluated using component analysisaccording to the methodological recommendations. Results: 5,559 new TC cases were registered during the 10-yearstudy period. The average age of patients was 52.0±0.2 years, the average annual age-standardized rate in 2009-2018was 3.3±0.20/0000, with a constant upward trend (Т=+6.6%). According to the component analysis results, the increasein incidence was mainly due to the combined effect of the two factors: the increased disease risk (ΔR=+61.7%), andthe population growth (ΔP=+15.4%). Conclusion: The noted increase in incidence was mainly caused by the changesin risk factors, such as the worsening environmental aspects and the increase in detection of clinically non-manifestingcases. The results of the study shall be taken into account when planning anticancer activities for TC.
کلید واژگان
Thyroid cancerIncidence
Component analysis
Kazakhstan
Public Health Epidemiology
شماره نشریه
9تاریخ نشر
2019-09-011398-06-10
ناشر
West Asia Organization for Cancer Prevention (WAOCP)سازمان پدید آورنده
Astana Medical University, Nur-Sultan, Kazakhstan.Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.
Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
Astana Medical University, Nur-Sultan, Kazakhstan.
شاپا
1513-73682476-762X




